Kestra Medical Technologies develops wearable cardiac devices and connected digital tools for patients at elevated risk of sudden cardiac arrest. Its flagship Cardiac Recovery System centers on the ASSURE wearable cardioverter defibrillator, which monitors heart rhythms and can deliver automated defibrillation, paired with a patient app and the CareStation remote data platform for clinicians. The offering targets post-event or high-risk cardiac patients under physician oversight.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q3 2025 | 19.4 | — | -25.8 | — |
| Q4 2025 | 22.6 | — | -32.8 | — |
| Q1 2026 | 24.6 | — | -34.2 | — |
| Q2 2026 | 28.6 | — | -38.8 | — |
| Q3 2026 | 31 | 59.9% | -44.1 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Distribution Solutions Group, Inc. (DSGR), Zenas BioPharma, Inc. (ZBIO), QCR Holdings, Inc. (QCRH), NextNav Inc. (NN), Hub Group, Inc. (HUBG), Omnicell, Inc. (OMCL)